Michigan Medicine expands precision oncology program in Lansing

University of Michigan Health-Sparrow and Michigan Medicine are expanding their precision oncology program in Lansing to tailor cancer treatments based on individual genetic profiles. The initiative, discussed by leaders at the Herbert-Herman Cancer Center, focuses on analyzing the specific genetic makeup of a patient’s tumor rather than applying a standardized treatment plan.

Gordon Srkalobic, co-director of the Precision Oncology Program at U of M Health, explained that the approach identifies specific mutated genes driving cancer growth. By targeting these genes with specific medications, doctors aim to block the growth pathways responsible for the disease’s progression in each patient.

Read the full story at WILX.